Whole Genome Association Study to Identify and Validate Genes for Restenosis: CardioGene Validation Proposal

Coronary Restenosis Clinical Trial

Official title: Whole Genome Association Study to Identify and Validate Genes for Restenosis: CardioGene Validation Proposal

Status Completed

Clinical Trial Summary

In this replication study at the Cleveland Clinic, we seek to collaborate to validate findings of the CardioGene Study in an independent cohort of patients who have undergone bare metallic stenting.

Clinical Trial Description

Dr. Elizabeth Nabel, Dr. Santhi K. Ganesh and colleagues at the National Institutes of Health have completed a genetic association study, entitled the CardioGene Study, using 100,000 SNPs spanning the entire human genome in subjects with restenosis after percutaneous intervention using bare metallic stents (Ganesh SK, 2004). In this replication study at the Cleveland Clinic, we seek to collaborate to validate findings of the CardioGene Study in an independent cohort of patients who have undergone bare metallic stenting. This study will examine samples and clinical data collected of subjects undergoing cardiac catheterization who meet study criteria, selected from the GeneBank. In the Genebank repository, subjects are informed their samples may be used indefinitely for study and consent to having their data/samples shared with other investigators at the Cleveland Clinic or other collaborating institutions. No information that might identify subjects is shared with collaborating investigators and samples will be shared in a de-identified manner, using assigned study numbers. ;

Related Conditions & MeSH terms

• Coronary Restenosis

• NCT number: NCT00589810
• Study type: Observational
• Source: The Cleveland Clinic
• Status: Completed
• Phase: N/A
• Start date: August 2007
• Completion date: November 2011